Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1177/2048872620922790

http://scihub22266oqcxt.onion/10.1177/2048872620922790
suck pdf from google scholar
32363880!7235633!32363880
unlimited free pdf from europmc32363880    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid32363880      Eur+Heart+J+Acute+Cardiovasc+Care 2020 ; 9 (3): 209-214
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Medical treatment options for COVID-19 #MMPMID32363880
  • Delang L; Neyts J
  • Eur Heart J Acute Cardiovasc Care 2020[Apr]; 9 (3): 209-214 PMID32363880show ga
  • Therapeutic options for coronavirus disease 2019 are desperately needed to respond to the ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs and immunomodulators might have their place in the management of coronavirus disease 2019. Unfortunately, no drugs have been approved yet to treat infections with human coronaviruses. As it will take years to develop new therapies for severe acute respiratory syndrome coronavirus 2, the current focus is on the repurposing of drugs that have been approved or are in development for other conditions. Several clinical trials have already been conducted or are currently ongoing to evaluate the efficacy of such drugs. Here, we discuss the potential of these therapies for the treatment of coronavirus disease 2019.
  • |Adenosine Monophosphate/administration & dosage/*analogs & derivatives/pharmacology/therapeutic use[MESH]
  • |Administration, Intravenous[MESH]
  • |Alanine/administration & dosage/*analogs & derivatives/pharmacology/therapeutic use[MESH]
  • |Amides/pharmacology/therapeutic use[MESH]
  • |Antibodies, Monoclonal, Humanized/pharmacology/therapeutic use[MESH]
  • |Antiviral Agents/administration & dosage/pharmacology/therapeutic use[MESH]
  • |Betacoronavirus/*drug effects[MESH]
  • |COVID-19[MESH]
  • |Chloroquine/adverse effects/*toxicity[MESH]
  • |Clinical Trials as Topic[MESH]
  • |Coronavirus Infections/*drug therapy/epidemiology[MESH]
  • |Cytochrome P-450 CYP3A Inhibitors/pharmacology/therapeutic use[MESH]
  • |Granulocyte-Macrophage Colony-Stimulating Factor/administration & dosage/pharmacology/therapeutic use[MESH]
  • |Humans[MESH]
  • |Immunologic Factors/therapeutic use[MESH]
  • |Lopinavir/pharmacology/therapeutic use[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/*drug therapy/epidemiology[MESH]
  • |Pyrazines/pharmacology/therapeutic use[MESH]
  • |RNA, Viral/drug effects[MESH]
  • |Recombinant Proteins/administration & dosage/pharmacology/therapeutic use[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box